Patents by Inventor Judith Newmark

Judith Newmark has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ADENO-ASSOCIATED VIRUS (AAV) SYSTEMS FOR TREATMENT OF PROGRANULIN ASSOCIATED NEURODEGENERATIVE DISEASES OR DISORDERS
    Publication number: 20240318199
    Abstract: The disclosure provides, in part, optimally-modified progranulin (PGRN) cDNA and associated genetic elements for use in recombinant adeno-associated virus (rAAV)-based gene therapy for neurodegenerative disorders characterized by cognitive disruption, behavioral impairment, and deficient lysosomal storage, including familial frontotemporal dementia (FTD), frontotemporal lobar degeneration (FTLD), neuronal ceroid lipofuscinosis (NCL), or Alzheimer's disease (AD).
    Type: Application
    Filed: September 26, 2023
    Publication date: September 26, 2024
    Inventors: Juan Li, Tanaz Farivar, Savitri Mandapati, Steven Pennock, Mark Shearman, Judith Newmark, Adrian M. Timmers
  • ADENO-ASSOCIATED VIRUS (AAV) SYSTEMS FOR TREATMENT OF PROGRANULIN ASSOCIATED NEURODEGENERATIVE DISEASES OR DISORDERS
    Publication number: 20210147872
    Abstract: The disclosure provides, in part, optimally-modified progranulin (PGRN) cDNA and associated genetic elements for use in recombinant adeno-associated virus (rAAV)-based gene therapy for neurodegenerative disorders characterized by cognitive disruption, behavioral impairment, and deficient lysosomal storage, including familial frontotemporal dementia (FTD), frontotemporal lobar degeneration (FTLD), neuronal ceroid lipofuscinosis (NCL), or Alzheimer's disease (AD).
    Type: Application
    Filed: October 22, 2020
    Publication date: May 20, 2021
    Inventors: Juan Li, Tanaz Farivar, Savitri Mandapadi, Steven Pennock, Mark Shearman, Judith Newmark, Adrian Timmers
  • ADENO-ASSOCIATED VIRUS (AAV)VECTORS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND OTHER OCULAR DISEASES AND DISORDERS
    Publication number: 20210123076
    Abstract: The present invention provides isolated promoters, transgene expression cassettes, vectors, kits, and methods for treatment of age-related macular generation and other genetic diseases that affect the cone cells of the retina.
    Type: Application
    Filed: October 22, 2020
    Publication date: April 29, 2021
    Inventors: Mark Shearman, Adrian M Timmers, Judith Newmark, Steven Pennock, Rakshaa Mureli, Chunjuan Song, Lisa Keyes